JENNIFER SHIELDS: Open Payments
NPI 1376258319 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,570 in 66 payments from 25 companies in 2025. Trend: 2023 $823 · 2024 $1,666 · 2025 $1,570
Food & beverage: $1,570
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $403 |
| Lilly USA, LLC | 9 | $135 |
| GlaxoSmithKline, LLC. | 8 | $135 |
| Exact Sciences Corporation | 5 | $97 |
| PFIZER INC. | 5 | $96 |
| Novo Nordisk Inc | 5 | $92 |
| ABBVIE INC. | 4 | $73 |
| GENZYME CORPORATION | 1 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Dexcom, Inc. | 2 | $43 |
Products named: AIRSUPRA, BREZTRI, TRELEGY ELLIPTA, MOUNJARO, DUPIXENT, JARDIANCE, The Cologuard Plus Collection Kit, Cologuard Collection Kit.
Industry payments across LA — which companies pay providers there.
